About Contact Us Careers

Hydrocodone Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3763
Published Date: Sep 19, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Hydrocodone Landscape

Teva Pharmaceuticals Industries Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Gilead Sciences, Inc.
Novartis AG
Sanofi-aventis Groupe
Abbott Laboratories
Merck & Co., Inc.
Siemens Healthcare GmbH
Pfizer Inc.
Eli Lilly and Company
BioControl Medical

Browse Key Market Insights with Data Illustration:

Hydrocodone Market Size & Share, Growth Report 2036

In the News

January, 2018: The U.S. Food and Drug Administration announced the change in safety labelling for cough and cold medications which contain codeine or hydrocodone. The consumption of these drugs will be restricted or limited for pediatric use.

Author Credits: Radhika Pawar

Report ID: 3763
Published Date: Sep 19, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing demand for hydrocodone-based painkillers is estimated to boost the market growth.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2022 â€“ 2030.

Regulations regarding the use of narcotics, and the addictive nature of opioids, are estimated to hamper the market growth.

The market in the North America region is estimated to provide more business opportunities over the forecast period, owing to the favorable policies for research involving narcotics for medical use.

The major players in the market are Gilead Sciences, Inc., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., Eli Lilly and Company, BioControl Medical, and others.

Inquiry Before Buying Request Free Sample